Dr. Reddy’s launches Dutas for treatment of enlarged prostate.
Hyderabad, India, April 19 2004:
Dr. Reddy’s has launched Dutas (generic name: dutasteride), for the treatment of enlarged prostate. Dr. Reddy’s is the first company to launch this drug in India.
Symptomatic enlarged prostate affects around 55% of men over the age of 50 and almost 90% over the age of 70 worldwide. In India there are over 77 million men over the age of 60 who are affected by this disease. It is a progressive disease with obstructive urinary symptoms that worsen with age. Until about ten years ago, the only treatment was surgery. The medical management of symptomatic enlarged prostate is now well established and offers the convenience of oral treatment as opposed to surgery.
Commenting on the launch, Mr Jaspal Singh Bajwa, President, Branded Formulations business, Dr. Reddy’s, said, “Dr. Reddy’s was the first company to introduce medical management of symptomatic enlarged prostate in India with the launch of its brand Finast (generic name: finasteride) in 1996. Dutasteride addresses the medical need of not only managing the symptoms but also helps in arresting disease progression".
About Dr. Reddy's
Established in 1984, Dr. Reddy's Laboratories (NYSE: RDY) is an emerging global pharmaceutical company with proven basic research capabilities. The company is vertically integrated with a presence across the pharmaceutical value chain. It produces finished dosage forms, active pharmaceutical ingredients and biotechnology products and markets them globally, with focus on India, US, Europe and Russia. The Company conducts research in the areas of cancer, diabetes, cardiovascular, inflammation and bacterial infection.
Disclaimer
This press release includes forward-looking statements, as defined in the U.S. Private Securities Litigation Reform Act of 1995. We have based these forward-looking statements on our current expectations and projections about future events. Such statements involve known and unknown risks, uncertainties and other factors that may cause actual results to differ materially. Such factors include, but are not limited to, changes in local and global economic conditions, our ability to successfully implement our strategy, the market acceptance of and demand for our products, our growth and expansion, technological change and our exposure to market risks. By their nature, these expectations and projections are only estimates and could be materially different from actual results in the future.
Notes to the Editor
The enlargement of the prostate gland is caused by dihydrotestosterone(DHT) which is converted from the male sex hormone testosterone by the enzyme 5 alpha reductase. Dutasteride by blocking this enzyme provides a near total suppression of DHT and thereby helps in reduction of symptoms due to enlarged prostate.
Contact Information
Media: R Rammohan at rammohanr@drreddys.com or on +91-40-55511620 or Pratap Antony at pratapa@drreddys.com or on +91-40-55511634.
Investors and Financial Analysts: Nikhil Shah at nikhilshah@drreddys.com or on +91-40-55511532.
피나스트, 피낵스로 우리에게도 익숙한 Dr.Reddy's 에서 두타스테라이드 카피약 두타스를 내놨습니다.
아직 정상적으로 시장에 나온거 같지는 않구요 medicinedrugstore 도 리뉴얼 중이라 구하기는 쉽지 않습니다.
조만간 구입법이 알려지리라 생각이 됩니다.
본 게시물의 내용은 이용자의 개인적인 경험 및 공개된 일반 정보를 바탕으로 작성된 것으로, 특정 의약품의 광고, 홍보 또는 사용을 권유하기 위한 목적이 아닙니다.
전문의약품의 사용 여부 및 치료에 관한 사항은 반드시 의료 전문가와 상담하시기 바랍니다.
탈모용사
탈모는극복하는것
K4817292865
K5013152061
두랩
레고마스터
압구정 맘모스헤어라인의원 
모더함의원 모발이식센터 
모프로의원 
참닥터모발이식의원 
모나라피부과의원 
모다올의원 
모원성형외과의원 
JP성형외과 
뉴헤어모발성형외과의원 
헤어로의원 대구점 
연세모벨르의원 인천점 
용닥터의원 
모엠의원 
광주 압구정모비앙의원 
연세모벨르의원 종로본점 
모모성형외과의원 
한나이브모발이식센터 
모우림의원 
노블라인의원 
알파모의원 
모바른의원 
헤어로의원 동탄점 
인천 맘모스헤어라인의원 
부산 리즈모 
부산 맘모스헤어라인의원 
모모의원 대구점 
모제림성형외과의원 
헤어로의원 부산점 
헤어로의원 전주점 
모앤블레스모발이식 
모디헤어플란트의원 
인천 마이모 모발이식의원 
자라다의원 
모우다의원 
모든모의원 
모모의원 부산점 
모재성모발이식센터 
바람부는날에도 성형외과의원 
모아트의원 
헤어로의원 청주점 
움찬의원 
모모의원 수원점 
모먼트의원 
다나성형외과 
연세모벨르의원 대구점 
글로웰의원 
모션모발이식의원 
모아만의원 
댓글